TrialDiabetes, obesity & metabolism2020

Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials.

Annemarie B van der Aart-van der Beek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.